Welcome to the Internal Medicine Intern Teaching Conference Series

Size: px
Start display at page:

Download "Welcome to the Internal Medicine Intern Teaching Conference Series"

Transcription

1 Welcome to the Internal Medicine Intern Teaching Conference Series Melissa (Moe) Hagman, MD, FACP University of Washington Internal Medicine & Palliative Care pager

2 Intern Teaching Conferences Objectives Provide information on topics of importance to new medicine interns Provide a forum for interns to share insights & questions regarding patient care

3 Intern Teaching Conferences AM Thursday Conferences July 1 August 5, UWMC Interns Report HMC Thursday 11:30am-12:30pm SVAMC Thursday noon-1pm UW Friday noon-1pm ***Please provide feedback***

4 Intern Teaching Conference What to Do When You Are Called to See a Patient with Pain July 1, 2010

5 Choosing a Pain Medication Flavor, dose, route, interval

6 Ms. M RN calls to report that Ms. M is having 10/10 right hip pain Acetaminophen 500mg po q6hrs prn is not working

7 Ms. M Sign-out 75 yo woman Full code Fall from standing with R hip fracture; to OR in AM for repair by Orthopedics Meds dalteparin, acetaminophen NTD Avoid CNS active medications due to risk of delirium

8 Ms. M Hx pain indeed appears to be from hip fracture PE Afeb, BP 156/92, HR 88, RR 16, O2 sat 97%RA AOx4, can parrot sequences of numbers up to 5 in a row forward Allergies NKDA

9 What order would you write to try to improve Ms. M s pain control? 1. Add ibuprophen 600mg poq8hrs prn pain 2. d/c acetaminophen & start percocet 5/325mg poq4hrs prn pain 3. Add oxycodone 2.5-5mg poq4hrs prn pain 4. Add morphine 1-2mg IV q4hrs prn pain 25% 25% 25% 25%

10 World Health Organization s Stepwise Analgesia Ladder Step Pain Drug I Mild Non-opioid (acetaminophen, NSAIDS) II Moderate Non-opioid plus weak opioid (hydrocodone, codeine, oxycodone) III Severe Non-opioid plus strong opioid (morphine, hydromorphone, fentanyl, etc.) AAHPM. UNIPAC Series: Hospice/Palliative Care Training for Physicians

11 Non-Opioid Analgesia Acetaminophen and/or NSAIDs can augment the pain relief provided by narcotics Consider scheduled acetaminophen Avoid NSAIDs in the elderly all together Renal failure, CHF, GIB Careful with inpatient NSAIDS in general Renal failure (especially if volume depletion) GI bleeding risk Other bleeding risk (including surgical)

12 Non-Opioid Analgesia Caution when using combination pills Acetaminophen is most common cause of acute liver failure in United States Patients forget that acetaminophen is present in many OTC medications No more than 4000 mg acetaminophen/day Consider prescribing acetaminophen and/or NSAIDs separately

13 Initiating Narcotics In renal insufficiency: methadone and fentanyl optimal oxycodone and hydromorphone with caution AVOID morphine and codeine In hepatic insufficiency: fentanyl, hydromorphone, oxycodone, and methadone with caution AVOID morphine Avoid use of meperidine because of risk of seizure in most situations

14 Ms. M Schedule acetaminophen 1000mg po QID (or q6hrs if you want her woken up) Max 4000mg a day For elderly, start narcotics at half usual starting dose and follow closely Oxycodone 2.5-5mg po q4hrs prn pain

15 If oral oxycodone not effective or you want an IV narcotic, what order would you write for Ms. M? 1. Morphine 1-2mg IV q4hrs prn pain 2. Morphine 0.5mg IV q4hrs prn pain 3. Hydromorphone 1-2mg IV q4hrs prn pain 4. Hydromorphone 0.2mg IV qhrs prn pain 25% 25% 25% 25%

16 Narcotic Equianalgesic Doses Drug PO IV Morphine 30 mg 10 mg Oxycodone 20 mg --- Hydromorphone 7.5 mg 1.5 mg Hydrocodone 30 mg mg morphine IV 0.15 mg hydromorphone IV 1.5 mg hydromorphone IV = X 10mg MS IV 1mg MS IV

17 Ms. M 3 Days Later Ms. M is POD#2 for surgical repair of hip Now complains of abdominal pain and no BM for 4 days.

18 Initiating Narcotics Always consider prophylactic medications to prevent constipation Docusate 250 mg po bid Senna 2 tabs po qhs others If concern for prior narcotic-induced nausea give an antiemetic with the narcotic for approximately 3 days until tolerance to nausea side effect has developed

19 Mr. G RN calls to report that Mr. G is having 9/10 back pain Acetaminophen 1000mg PR qid and morphine 1-2 mg IV q4hrs are not working

20 Mr. G Sign-out 73 yo gentleman Metastatic prostate cancer on hormonal therapy; receiving XRT to spine Admitted with nausea/vomiting (thought to be partial SBO) and renal failure Meds acetaminophen, morphine, antiemetic, bisacodyl PR, IVF NTD

21 You go see Mr. G: Mr. G complains of baseline diffuse bony discomfort relieved by acetaminophen and morphine ER 60 mg po q 12hr + morphine IR two 15 mg tabs/day feels like he is not getting enough pain medication since switched from home pills to IV meds in hospital Should he continue morphine? What can we do for his pain?

22 Narcotic Conversions Morphine ER 60 mg po q 12hr + morphine IR two 15 mg tabs/day = 120 mg + 30 mg = 150 mg total/day Decrease dose by 1/3 rd to half for incomplete cross tolerance when changing narcotics 150 mg/day x 2/3 = 100 mg/day morphine (to convert to fentanyl)

23 Narcotic Conversion to Fentanyl Oral Morphine/24hr Initial Fentanyl Patch 90 mg 25 mcg/hr 180 mg 50 mcg/hr 360 mg 75 mcg/hr 100 mg/day morphine dose patches q72hrs full dose onset 12hrs

24 Now that fentanyl patch in place, what order would you write for break through pain for Mr. G? 1. Morphine 10mg SL q4hrs prn pain 2. Morphine 3mg IV q4hrs prn pain 3. Oxycodone liquid 7.5mg poq4hrs prn pain 4. Hydromorphone 0.5mg IV q4hrs prn pain 25% 25% 25% 25%

25 Narcotic Conversions Breakthrough dose = 10% of total daily dose 150 mg/day x 2/3 = 100 mg/day morphine (10% for break through = 10 mg morphine)

26 Narcotic Equianalgesic Doses Drug PO IV Morphine 30 mg 10 mg Oxycodone 20 mg --- Hydromorphone 7.5 mg 1.5 mg Hydrocodone 30 mg mg morphine po 0.5 mg hydromorphone IV 1.5 mg hydromorphone IV = X 30mg MS PO 10mg MS PO

27 Narcotic Conversions Breakthrough dose = 10% of total daily dose Decrease total daily dose by 1/3 rd to half for incomplete cross tolerance when changing narcotics (Avoid morphine in renal and/or liver failure)

28 Narcotic Conversions Morphine ER 60 mg po q 12hr + morphine IR two 15 mg tabs/day = 120 mg + 30 mg = 150 mg total/day Decrease dose by 1/3 rd to half for incomplete cross tolerance when changing narcotics 150 mg/day x 2/3 = 100 mg/day morphine (to convert to hydromorphone)

29 Narcotic Equianalgesic Doses Drug PO IV Morphine 30 mg 10 mg Oxycodone 20 mg --- Hydromorphone 7.5 mg 1.5 mg Hydrocodone 30 mg mg morphine po 5 mg hydromorphone IV 1.5 mg hydromorphone IV = X 30mg MS PO 100mg MS PO

30 Narcotic Conversions 100 mg morphine po 5 mg hydromorphone IV 5 mg hydromorphone IV/24hrs = 0.2 mg/hr PCA order 0.2 mg/hr continuous infusion hourly rate q6min prn breakthrough pain

31 Mr. T RN from the Medicine floor calls you on crosscover to report that Mr. T, a 25 yo male admitted last night with endocarditis, is becoming agitated, complaining of pain, and demanding METHADONE!

32 Mr. T Sign-out 25 yo gentleman Full code Longstanding heroin addiction; admitted last night with presumed endocarditis Meds vancomycin, acetaminophen NTD

33 Approach to Evaluating Patients with Opioid Withdrawal Know the signs & symptoms pupillary dilatation, lacrimation, rhinorrhea, piloerection, yawning, sneezing, anorexia, nausea, vomiting, diarrhea Peak heroin withdrawal hrs, lasts 7-10 d Peak methadone w/d hrs, last >14 d Ask about: other drugs the patient may be using illicitly history of methadone maintenance patient s wishes regarding detox or no detox during this trip to the hospital

34 Mr. T Patient denies other illicit drug use except for heroin I use 3 grams a day! He wants methadone Says he usually gets 120 mg a day when he is in the hospital

35 What order would you write for Mr. T? 1. Methadone 20mg po x1, then 5mg po q2-3hrs prn until sxs resolve 2. Methadone 120mg po qday, hold for sedation 3. Oxycodone 5-10mg po q4hrs prn withdrawal sxs 33% 33% 33% 1 2 3

36 Management of Opioid W/D in Patients Not Requesting Detox Treat or prevent acute withdrawal Otherwise medical condition may not be adequately managed Methadone starting dose Methadone 20 mg po times 1, then 5 mg po q2-3h until symptoms resolve (max 60 mg a day) Primary team can see how much methadone was used overnight and come up with qd or tid dosing regimen

37 Management of Opioid W/D in Patients Requesting Detox Treat symptoms clonidine = GI distress, diaphoresis, piloerection, muscle aches NSAIDS = muscle aches promethazine (Phenergan) = nausea hydroxyzine (Vistaril) = itching, agitation Immodium = diarrhea

38 Mr. T 10 Days Later RN calls you on crosscover to report that Mr. T is becoming agitated, complaining of pain, and demanding MORE METHADONE!

39 Mr. T Sign-out 25 yo gentleman Full code Longstanding heroin addiction; endocarditis Meds nafcillin, gentamicin, rifampin, methadone 60mg qam, acetaminophen NTD

40 Methadone in General Some meds decrease methadone level Rifampin Phenytoin, steroids, carbamazepine, some antiretrovirals Some meds increase methadone levels Amitriptyline, ketoconazole, macrolides, fluoroquinolones, SSRIs, diazepam

41 Methadone in General Long, variable half-life (up to 190hrs) In general, do not increase dose more than once every 3-4 days Always write hold for sedation Dose conversion complex involve pharmacy

42 Ms. D RN calls to report that Ms. D is having new 6/10 suprapubic pain Acetaminophen 500 mg po q4hrs prn not helping

43 Ms. D Sign-out 41 yo woman Metastatic breast cancer to brain Admitted for pain control and brain XRT Meds prednisone, morphine (recently increased), acetaminophen, antiemetic NTD

44 Some Side Effects of Opioids Urinary retention Rx: Foley, decrease opioid dose, BPH meds in men Constipation Rx: senna, docusate Rx: polyethylene glycol, MOM, lactulose, bisacodyl, enema Confusion Search for underlying causes other than opioids Myoclonus Reduce dose or change to a different opioid

45 Ms. D 3 Days Later RN calls to report that Ms. D is not arousable and RR 8

46 Ms. D Sign-out 41 yo woman DNAR/DNI Metastatic breast cancer to brain Admitted for pain control and brain XRT Meds prednisone, morphine (recently increased), acetaminophen, antiemetic NTD

47 Naloxone RR 8-12/min in resting patient is usually OK (especially if the goal of care is comfort) Be careful though in patients on chronic opioids, naloxone can precipitate withdrawal & pain If you must give naloxone to patient on chronic opioids: Dilute 1 amp (0.4mg) in 10ml of saline and give 1ml IV q5 minutes

48 Remember to Call Your Resident if You Have ANY Questions There are no badges for independence, bravery, courage

Welcome to the Internal Medicine Intern Teaching Course

Welcome to the Internal Medicine Intern Teaching Course Welcome to the Internal Medicine Intern Teaching Course Melissa (Moe) Hagman, MD, FACP University of Washington Internal Medicine & Palliative Care mhagman@u.washington.edu pager 206-540-9725 Intern Teaching

More information

Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients

Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients Developed by the Mid Atlantic Renal Coalition and the Kidney End of Life Coalition September 2009 This project was supported,

More information

OPIOID CONVERSIONS. 2. Add a rescue doses (IR) of same opioid if possible should be~10 20% of total daily opioid dose

OPIOID CONVERSIONS. 2. Add a rescue doses (IR) of same opioid if possible should be~10 20% of total daily opioid dose OPIOID CONVERSIONS 1. Converting Short acting Long Acting (IR SR) when pain is well controlled *Use for : CHRONIC pain Pts on scheduled IR opioids pain that recurs before the next dose PP: Can use equianalgesic

More information

Review of Pharmacological Pain Management

Review of Pharmacological Pain Management Review of Pharmacological Pain Management CHAMP Activities are possible with generous support from The Atlantic Philanthropies and The John A. Hartford Foundation The WHO Pain Ladder The World Health Organization

More information

POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics

POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics POST-TEST University of Wisconsin Hospital & Clinics True/False/Don't Know - Circle the correct answer T F D 1. Changes in vital signs are reliable indicators of pain severity. T F D 2. Because of an underdeveloped

More information

Nurses Self Paced Learning Module on Pain Management

Nurses Self Paced Learning Module on Pain Management Nurses Self Paced Learning Module on Pain Management Dominican Santa Cruz Hospital Santa Cruz, California Developed by: Strategic Planning Committee Dominican Santa Cruz Hospital 1555 Soquel Drive Santa

More information

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: Frenchay 0117 340 6692 Southmead 0117 323

More information

AGS. PAIN MANAGEMENT FOR THE SURGICAL RESIDENT (in 30 min or less)

AGS. PAIN MANAGEMENT FOR THE SURGICAL RESIDENT (in 30 min or less) AGS PAIN MANAGEMENT FOR THE SURGICAL RESIDENT (in 30 min or less) THE AMERICAN GERIATRICS SOCIETY Geriatrics Health Professionals. Leading change. Improving care for older adults. CASE PRESENTATION 46-year-old

More information

Pain Control Aims. General principles of pain control. Basic pharmacokinetics. Case history demo. Opioids renal failure John Welsh 8/4/2010

Pain Control Aims. General principles of pain control. Basic pharmacokinetics. Case history demo. Opioids renal failure John Welsh 8/4/2010 Pain Control Aims General principles of pain control Basic pharmacokinetics Case history demo Opioids renal failure John Welsh 8/4/2010 Pain Control Morphine is gold standard treatment for moderate to

More information

October 2012. We hope that our tool will be a useful aid in your efforts to improve pain management in your setting. Sincerely,

October 2012. We hope that our tool will be a useful aid in your efforts to improve pain management in your setting. Sincerely, October 2012 he Knowledge and Attitudes Survey Regarding Pain tool can be used to assess nurses and other professionals in your setting and as a pre and post test evaluation measure for educational programs.

More information

Pain Management. Mehraneh Khalighi, MD Original Date/Last Reviewed: January 2009/March 2010

Pain Management. Mehraneh Khalighi, MD Original Date/Last Reviewed: January 2009/March 2010 Mehraneh Khalighi, MD Original Date/Last Reviewed: January 2009/March 2010 Pain Management Learning Objectives- Identify most common barriers to effective treatment of pain. Describe principles of effective

More information

Cancer Pain Role Model Program Case Studies and Faculty Guides. Wisconsin Cancer Pain Initiative Madison, Wisconsin

Cancer Pain Role Model Program Case Studies and Faculty Guides. Wisconsin Cancer Pain Initiative Madison, Wisconsin Cancer Pain Role Model Program Case Studies and Faculty Guides Wisconsin Cancer Pain Initiative Madison, Wisconsin Developed by: David Weissman, MD June L. Dahl, PhD WISCONSIN CANCER PAIN INITIATIVE CANCER

More information

Opioid Addiction & Methadone Maintenance Treatment. What is Methadone? What is an Opioid?

Opioid Addiction & Methadone Maintenance Treatment. What is Methadone? What is an Opioid? Opioid Addiction & Methadone Maintenance Treatment Dr. Nick Wong MD, CCFP AADAC Edmonton ODP AADAC AHMB Concurrent Disorder Series September 13, 2007 1 What is Methadone? What is methadone? Synthetic opioid.

More information

Pain Management in Palliative and Hospice Care

Pain Management in Palliative and Hospice Care Pain Management in Palliative and Hospice Care Donna Butler, MSN, ANP-BC, OCN, ACHPN, FAAPM Current Status of Pain Cancer patients at EOL- 54% have pain AIDS with prognosis < 6mons- intense pain Less research

More information

How to take your Opioid Pain Medication

How to take your Opioid Pain Medication How to take your Opioid Pain Medication Today your doctor gave you a prescription for medication to help relieve your pain. The pain medication is called an opioid or narcotic. Taking pain medication,

More information

Pain Management Case Studies. Adapted from: IMPROVING END-OF-LIFE CARE A RESOURCE GUIDE FOR PHYSICIAN EDUCATION

Pain Management Case Studies. Adapted from: IMPROVING END-OF-LIFE CARE A RESOURCE GUIDE FOR PHYSICIAN EDUCATION Pain Management Case Studies Adapted from: IMPROVING END-OF-LIFE CARE A RESOURCE GUIDE FOR PHYSICIAN EDUCATION 3rd Edition David E. Weissman, MD Director, Palliative Care Program Medical College of Wisconsin

More information

Opioids, Benzos, and Tapering, Oh My! Disclosures

Opioids, Benzos, and Tapering, Oh My! Disclosures Opioids, Benzos, and Tapering, Oh My! Melissa B. Weimer, DO, MCR March 10, 2016 Disclosures Dr. Weimer is a paid consultant for INFORMed and a speaker for IMPACT education. Dr. Weimer is the medical director

More information

New England Pediatric Sickle Cell Consortium

New England Pediatric Sickle Cell Consortium New England Pediatric Sickle Cell Consortium Management of Acute Pain in Pediatric Patients with Sickle Cell Disease (Vaso-Occlusive Episodes) Disclaimer Statement: Hospital clinical pathways are designed

More information

Pain management. The WHO analgesic ladder

Pain management. The WHO analgesic ladder Pain management Successful treatment requires an accurate diagnosis of the cause and a rational approach to therapy. Most pains arise by stimulation of nociceptive nerve endings; the characteristics may

More information

Management of Patients with Narcotic Bowel Syndrome(1)

Management of Patients with Narcotic Bowel Syndrome(1) Management of Patients with Narcotic Bowel Syndrome(1) Ademola Aderoju MD, Jacob Kurlander MD, Christina Davis, Patrick Barrett MD, Douglas A. Drossman MD Patients on chronic narcotics who have been diagnosed

More information

NALTREXONE INDUCED DETOXIFICATION FROM OPIOIDS A METHOD OF ANTAGONIST INITIATED TREATMENT

NALTREXONE INDUCED DETOXIFICATION FROM OPIOIDS A METHOD OF ANTAGONIST INITIATED TREATMENT NALTREXONE INDUCED DETOXIFICATION FROM OPIOIDS A METHOD OF ANTAGONIST INITIATED TREATMENT Opioid dependence is a devastating and frequently fatal medical condition. It is a manifestation of addictive disorder

More information

SAFE PAIN MEDICATION PRESCRIBING GUIDELINES

SAFE PAIN MEDICATION PRESCRIBING GUIDELINES Prescription drug abuse has been declared an epidemic by the Centers for Disease Control. According to 2012 San Diego Medical Examiner data, the number one cause of non-natural death is due to drug overdoses

More information

The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool

The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool The Pharmacological Management of Cancer Pain in Adults Clinical Audit Tool 2015 This clinical audit tool accompanies the Pharmacological Management of Cancer Pain in Adults NCEC National Clinical Guideline

More information

UNIT VIII NARCOTIC ANALGESIA

UNIT VIII NARCOTIC ANALGESIA UNIT VIII NARCOTIC ANALGESIA Objective Review the definitions of Analgesic, Narcotic and Antagonistic. List characteristics of Opioid analgesics in terms of mechanism of action, indications for use and

More information

Pain Medication Taper Regimen Time frame to taper off 30-60 days

Pain Medication Taper Regimen Time frame to taper off 30-60 days Pain Medication Taper Regimen Time frame to taper off 30-60 days Medication to taper Taper Regimen Comments Methadone Taper by no more than 25% Morphine Taper by no more than 25% Tramadol Taper by no more

More information

Hospital Management of Opioid Dependence. Dependence. Disclosure. Pharmacologic Management. Methadone Utilization. Hospital Management of Opioid

Hospital Management of Opioid Dependence. Dependence. Disclosure. Pharmacologic Management. Methadone Utilization. Hospital Management of Opioid Disclosure Hospital Management of Opioid Dependence Attended Buprenorphine advisory board meeting (Schering Canada) May 2007, but personal honorarium/compensation was declined Dr. Alex Chan alexchchan@hotmail.com

More information

PALLIATIVE CARE PAIN MANAGEMENT AND NON-PAIN SYMPTOMS ONLY

PALLIATIVE CARE PAIN MANAGEMENT AND NON-PAIN SYMPTOMS ONLY AN EXAMINATION OF KNOWLEDGE IN: PALLIATIVE CARE PAIN MANAGEMENT AND NON-PAIN SYMPTOMS ONLY (EPERC TEST #1) 40 QUESTIONS; MULTIPLE CHOICE; SINGLE-BEST ANSWER Supplied by: End of Life Physician Education

More information

Opioid Analgesics. Week 19

Opioid Analgesics. Week 19 Opioid Analgesics Week 19 Analgesic Vocabulary Analgesia Narcotic Opiate Opioid Agonist Antagonist Narcotic Analgesics Controlled substances Opioid analgesics derived from poppy Opiates include morphine,

More information

Understanding Your Pain

Understanding Your Pain Toll Free: 800-462-3636 Web: www.endo.com Understanding Your Pain This brochure was developed by Margo McCaffery, RN, MS, FAAN, and Chris Pasero, RN, MS, FAAN authors of Pain: Clinical Manual (2nd ed.

More information

OPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School

OPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School OPIOIDS Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School Rutgers New Jersey Medical School Fundamentals of Addiction Medicine Summer Series Newark, NJ July 24, 2013

More information

This module reviews the following: Opioid addiction and the brain Descriptions and definitions of opioid agonists,

This module reviews the following: Opioid addiction and the brain Descriptions and definitions of opioid agonists, BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module II Opioids 101 Goals for Module II This module reviews the following: Opioid addiction and the brain Descriptions

More information

Primary Care Behavioral Interventions for Pain and Prescription Opioid Misuse

Primary Care Behavioral Interventions for Pain and Prescription Opioid Misuse Primary Care Behavioral Interventions for Pain and Prescription Opioid Misuse J E F F R E I T E R, P H D, A B P P H E A L T H P O I N T C O M M U N I T Y H E A L T H C E N T E R S S P R I N G 2 0 1 3 A

More information

Hospice of Kitsap County's Guide for Physicians

Hospice of Kitsap County's Guide for Physicians Hospice of Kitsap County's Guide for Physicians Includes Medical Guidelines for Determining Prognosis Dear Doctor: Hospice of Kitsap County is providing you with these guidelines as part of Hospice s Physician

More information

Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal

Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal Roger Cicala, M. D. Assistant Medical Director Tennessee Physician s Wellness Program Step 1 Don t 1 It is legal in

More information

Case Studies: Acute pain management in patients with opioid addiction. Shannon Levesque, PharmD Clinical Pharmacist

Case Studies: Acute pain management in patients with opioid addiction. Shannon Levesque, PharmD Clinical Pharmacist Case Studies: Acute pain management in patients with opioid addiction Shannon Levesque, PharmD Clinical Pharmacist Disclosure I have no financial relationships with industry to disclose Objectives Misconceptions

More information

OPIOID NEUROTOXICITY - BACK TO BASICS. Dr. Suzy Pinnick (PGY-3): Palliative Medicine Fellow

OPIOID NEUROTOXICITY - BACK TO BASICS. Dr. Suzy Pinnick (PGY-3): Palliative Medicine Fellow OPIOID NEUROTOXICITY - BACK TO BASICS Dr. Suzy Pinnick (PGY-3): Palliative Medicine Fellow OBJECTIVES Some Cases Definitions: Including what is opioid neurotoxicity A bit of biochemistry What patients

More information

COMMUNITY BUPRENORPHINE PRESCRIBING IN OPIATE DEPENDENCE

COMMUNITY BUPRENORPHINE PRESCRIBING IN OPIATE DEPENDENCE COMMUNITY BUPRENORPHINE PRESCRIBING IN OPIATE DEPENDENCE INTRODUCTION High dose sublingual buprenorphine (Subutex) tablets are available in the following strengths 0.4 mg, 2 mg, and 8 mg. Suboxone tablets,

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT/FIT 2015 May 2015 Daniel P. Alford, MD, MPH, FACP, FASAM Associate Professor of Medicine Assistant Dean, Continuing Medical Education Director, Clinical Addiction Research

More information

Naloxone treatment of opioid overdose

Naloxone treatment of opioid overdose Naloxone treatment of opioid overdose Opioids Chemicals that act in the brain to relieve pain, often use to suppress cough, treat addiction, and provide comfort After prolonged use of opioids, increasing

More information

Lora McGuire MS, RN Educator and Consultant lmcguire@jjc.edu. Barriers to effective pain relief

Lora McGuire MS, RN Educator and Consultant lmcguire@jjc.edu. Barriers to effective pain relief Lora McGuire MS, RN Educator and Consultant lmcguire@jjc.edu Barriers to effective pain relief Freedom from pain is a basic human right -WHO Pain is whatever the experiencing person says it is and exists

More information

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes. Reference Guide for PACU Lumbar Fusion CLINICAL PATHWAY All patient variances to the pathway are to be circled and addressed in the progress notes. This Clinical Pathway is intended to assist in clinical

More information

WITHDRAWAL OF ANALGESIA AND SEDATION

WITHDRAWAL OF ANALGESIA AND SEDATION WITHDRAWAL OF ANALGESIA AND SEDATION Patients receiving analgesia and/or sedation for longer than 5-7 days may suffer withdrawal if these drugs are suddenly stopped. To prevent this happening drug doses

More information

1. Which of the following would NOT be an appropriate choice for postoperative pain. C. Oral oxycodone 5 mg po every 4 to 6 hours as needed for pain

1. Which of the following would NOT be an appropriate choice for postoperative pain. C. Oral oxycodone 5 mg po every 4 to 6 hours as needed for pain Pain Management 1 Chapter 34. Pain Management, Self-Assessment Questions 1. Which of the following would NOT be an appropriate choice for postoperative pain management in a patient dependent on opioids?

More information

MUSC Opioid Analgesic Comparison Chart

MUSC Opioid Analgesic Comparison Chart MUSC Opioid Analgesic Comparison Chart Approved by the Pharmacy and Therapeutics Committee (February 2006, November 2009, March 2010, December 2011) Prepared by the MUSC Department of Pharmacy Services

More information

Opioid Conversion Ratios - Guide to Practice 2013

Opioid Conversion Ratios - Guide to Practice 2013 Opioid s - Guide to Practice 2013 Released 1 st October 2013 2013. The EMR PCC grants permission to reproduce parts of this publication for clinical and educational use only, provided that the Eastern

More information

One example: Chapman and Huygens, 1988, British Journal of Addiction

One example: Chapman and Huygens, 1988, British Journal of Addiction This is a fact in the treatment of alcohol and drug abuse: Patients who do well in treatment do well in any treatment and patients who do badly in treatment do badly in any treatment. One example: Chapman

More information

PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications

PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications Primary Care & Specialist Prescribing Guidelines Introduction Partnership HealthPlan is a County Organized Health System covering

More information

Care Guide: Cancer Pain

Care Guide: Cancer Pain Care Guide: Cancer Pain Key Points: Cancer Pain Specific Pain Problems 1. Pain is defined as an independent and emotional experience associated with actual or potential tissue damage or described in terms

More information

Objectives. Mechanism-Based Therapy. The Approach to Nausea, Vomiting, and Pain at The End of Life

Objectives. Mechanism-Based Therapy. The Approach to Nausea, Vomiting, and Pain at The End of Life The Approach to Nausea, Vomiting, and Pain at The End of Life Thomas R. DeGregory D.O. CMD Hospice and Palliative Care Assessment Pathophysiology Treatment Objectives Mechanism-Based Therapy 1. Determine

More information

Opioid toxicity and alternative opioids. Palliative care fixed resource session

Opioid toxicity and alternative opioids. Palliative care fixed resource session Opioid toxicity and alternative opioids Palliative care fixed resource session Opioid toxicity and alternative opioids - aims Know the symptoms of opioid toxicity Understand which patients are at higher

More information

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Mark Fisher Program Administrator State Opioid Treatment Adminstrator Kentucky Division of Behavioral Health OBJECTIVES Learn about types of opioids and

More information

Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment

Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment I ve had breast cancer treatment, and now I m having pain. Does this mean the cancer

More information

MEDICATION ABUSE IN OLDER ADULTS

MEDICATION ABUSE IN OLDER ADULTS MEDICATION ABUSE IN OLDER ADULTS Clifford Milo Singer, MD Adjunct Professor, University of Maine, Orono ME Chief, Division of Geriatric Mental Health and Neuropsychiatry The Acadia Hospital and Eastern

More information

Management of Opiate Dependence in the Outpatient Setting

Management of Opiate Dependence in the Outpatient Setting Management of Opiate Dependence in the Outpatient Setting Abigail Kay, M.D., M.A. Abigail.Kay@Jefferson.edu Please Note: I have no conflicts of interest Medical Director Narcotic Addiction Rehabilitation

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2011 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy Category: Heroin Title: Methadone Maintenance vs 180-Day psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial Authors: Karen L. Sees, DO, Kevin L. Delucchi,

More information

Weaning off your pain medicine

Weaning off your pain medicine Weaning off your pain medicine UHN Information for patients taking opioid pain medicines Read this booklet to learn about: why you need to wean off your pain medicine how to wean off slowly how to control

More information

Implementing Prescribing Guidelines in the Emergency Department. April 16, 2013

Implementing Prescribing Guidelines in the Emergency Department. April 16, 2013 Implementing Prescribing Guidelines in the Emergency Department April 16, 2013 Housekeeping Note: Today s presentation is being recorded and will be provided within 48 hours. Two ways to ask questions

More information

Narcotic drugs used for pain treatment Version 4.3

Narcotic drugs used for pain treatment Version 4.3 Narcotic drugs used for pain treatment Version 4.3 Strategy to restrict the pack sizes or the type of packaging available in public pharmacies. 1. Introduction The document describing the strategy of the

More information

Safely Discontinuing Opioid Analgesics

Safely Discontinuing Opioid Analgesics www.pain-topics.com Safely Discontinuing Opioid Analgesics Author: Editor: Medical Reviewer: Lee A. Kral, PharmD, BCPS Stewart B. Leavitt, MA, PhD Jeffrey Fudin, BS, PharmD, DAAPM Release Date: March 2006

More information

Objectives. Pain Management Knowing How To Help Yourself. Patients and Family Requirements. Your Rights As A Consumer

Objectives. Pain Management Knowing How To Help Yourself. Patients and Family Requirements. Your Rights As A Consumer Objectives Pain Management Knowing How To Help Yourself Jackie Carter, RN MSN CNS Become familiar with the definitions of pain Be aware of your rights to have your pain treated Become familiar with the

More information

The ABCs of Medication Assisted Treatment

The ABCs of Medication Assisted Treatment The ABCs of Medication Assisted Treatment J E F F R E Y Q U A M M E, E X E C U T I V E D I R E C T O R C O N N E C T I C U T C E R T I F I C A T I O N B O A R D The ABCs of Medication Assisted Treatment

More information

Considerations when Using Controlled Substances to Treat Chronic Pain

Considerations when Using Controlled Substances to Treat Chronic Pain Considerations when Using Controlled Substances to Treat Chronic Pain By Mary-Beth F. Plum, Pharm.D. Impact of Chronic Pain Acute pain is the body s response to environmental dangers, and it helps protect

More information

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC Acute Pain Management in the Opioid Dependent Patient Maripat Welz-Bosna MSN, CRNP-BC Relieving Pain in America (IOM) More then 116 Million Americans have pain the persists for weeks to years $560-635

More information

Controlling Pain Part 2: Types of Pain Medicines for Your Prostate Cancer

Controlling Pain Part 2: Types of Pain Medicines for Your Prostate Cancer Controlling Pain Part 2: Types of Pain Medicines for Your Prostate Cancer The following information is based on the general experiences of many prostate cancer patients. Your experience may be different.

More information

Program Assistance Letter

Program Assistance Letter Program Assistance Letter DOCUMENT NUMBER: 2004-01 DATE: December 5, 2003 DOCUMENT TITLE: Use of Buprenorphine in Health Center Substance Abuse Treatment Programs TO: All Bureau of Primary Health Care

More information

Appendix 4: Guidelines for Prescribing and Administering Drugs:

Appendix 4: Guidelines for Prescribing and Administering Drugs: Appendix 4: Guidelines for Prescribing and Administering Drugs: A midwife may prescribe and administer the following substances in accordance with the guidelines approved by the Board. This list indicates

More information

Pain is a symptom people associate with a malignant illness and is common in non malignant disease.

Pain is a symptom people associate with a malignant illness and is common in non malignant disease. HAWKE S BAY DISTRICT HEALTH BOARD Manual: Clinical Guidelines Manual CRANFORD HOSPICE Doc No: HBDHB/IVTG/139 Issue Date: Review Date: 3 yearly Approved: Cranford Hospice Medical Pain in the Palliative

More information

Acute pain management for opioid tolerant patients CLASSIFICATION OF OPIOID TOLERANT PATIENTS

Acute pain management for opioid tolerant patients CLASSIFICATION OF OPIOID TOLERANT PATIENTS Update in Anaesthesia Acute pain management for opioid tolerant patients Simon Marshall and Mark Jackson* *Correspondence email: mark.jackson@rdeft.nhs.uk INTRODUCTION Opioid tolerance is usually encountered

More information

Pain Management in The Hospice Setting

Pain Management in The Hospice Setting Pain Management in The Hospice Setting Jerry L Old MD Associate Professor & Geriatrics Clerkship Director University of Kansas School of Medicine jold@kumc.edu Regional Medical Director Hospice Care of

More information

Pain, Addiction & Methadone

Pain, Addiction & Methadone Pain, Addiction & Methadone A CHALLENGING INTERFACE METHADONE AND SUBOXONE OPIOID SUBSTITUTION CONFERENCE Objectives 2 Explore the interface between concurrent pain and addiction. Appreciate the challenges

More information

Opioid Agreement for Center for Pain Management S.C.

Opioid Agreement for Center for Pain Management S.C. Opioid Agreement for Center for Pain Management S.C. Patient Name: DOB: I am the patient named above. I have agreed to use pain medication as part of my treatment for chronic pain. I understand that these

More information

Cancer Pain. What is Pain?

Cancer Pain. What is Pain? Cancer Pain What is Pain? The International Association for the Study of Pain says that pain is "an unpleasant sensory and emotional experience associated with actual or potential tissue damage." Pain

More information

Opioid Conversion Ratios - Guide to Practice 2013 Updated as Version 2 - November 2014

Opioid Conversion Ratios - Guide to Practice 2013 Updated as Version 2 - November 2014 Opioid s - Guide to Practice 2013 Updated as Version 2 - November 2014 2013. The EMR PCC grants permission to reproduce parts of this publication for clinical and educational use only, provided that the

More information

Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction

Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction June 9, 2011 Tufts Health Care Institute Program on Opioid Risk Management Daniel

More information

Opioid Dependence. Average Purity of Retail Heroin Street Samples in U.S

Opioid Dependence. Average Purity of Retail Heroin Street Samples in U.S Opioid Dependence Andrew J. Saxon, M.D. University of Washington, Seattle VA Puget Sound Health Care System Average Purity of Retail Heroin Street Samples in U.S 4 35 3 25 2 15 1 5 198's 1991 2 Source:

More information

Electronic Medical Record (EMR) Safety Results of CAH Testing. Tom Johns, PharmD Shands at the University of Florida

Electronic Medical Record (EMR) Safety Results of CAH Testing. Tom Johns, PharmD Shands at the University of Florida Electronic Medical Record (EMR) Safety Results of CAH Testing Tom Johns, PharmD Shands at the University of Florida Vendors Evaluated CPSI Healthland Cerner Test Patients Test Patient A Age: 76 y/o Sex:

More information

Medications for chronic pain

Medications for chronic pain Medications for chronic pain When it comes to treating chronic pain with medications, there are many to choose from. Different types of pain medications are used for different pain conditions. You may

More information

PAIN RELIEF GUIDE. Tips and advice from your pharmacist.

PAIN RELIEF GUIDE. Tips and advice from your pharmacist. PAIN RELIEF GUIDE Tips and advice from your pharmacist. Rite Aid Pharmacists: Your Pain Relief Managers Rite Aid is committed to providing everyday products and services that help our valued customers

More information

SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC

SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC Learning Objectives: 1. Identify the names and reasons/circumstances for additional toxicity of SELECTED OPIATES hydromorphone DILAUDID Methadone Fentanyl/DURAGESIC

More information

Update on Buprenorphine: Induction and Ongoing Care

Update on Buprenorphine: Induction and Ongoing Care Update on Buprenorphine: Induction and Ongoing Care Elizabeth F. Howell, M.D., DFAPA, FASAM Department of Psychiatry, University of Utah School of Medicine North Carolina Addiction Medicine Conference

More information

History of Malignant Pain: Treatment with Opioids. Dr. Kathleen M. Foley Pain, Opioids, and Addiction: An Urgent Problem for Doctors and Patients

History of Malignant Pain: Treatment with Opioids. Dr. Kathleen M. Foley Pain, Opioids, and Addiction: An Urgent Problem for Doctors and Patients History of Malignant Pain: Treatment with Opioids Dr. Kathleen M. Foley Pain, Opioids, and Addiction: An Urgent Problem for Doctors and Patients March 5-6, 5 2007 Some of the Questions that Must be Answered

More information

Management of Neonatal Abstinence Syndrome and Iatrogenic Drug Withdrawal

Management of Neonatal Abstinence Syndrome and Iatrogenic Drug Withdrawal Management of Neonatal Abstinence Syndrome and Iatrogenic Drug Withdrawal Kirsten H. Ohler, Pharm.D., BCPS Clinical Assistant Professor Neonatal / Pediatric Clinical Pharmacist University of Illinois at

More information

MODERATE SEDATION RECORD (formerly termed Conscious Sedation)

MODERATE SEDATION RECORD (formerly termed Conscious Sedation) (POLICY #DOC-051) Page 1 of 6 WELLSPAN HEALTH - YORK HOSPITAL NURSING POLICY AND PROCEDURE Dates: Original Issue: September 1998 Annual Review: March 2012 Revised: March 2010 Submitted by: Brenda Artz

More information

Opioids for Pain Treatment. Opioids for Chronic Pain and Addiction Treatment. Outline for Today. Opioids for pain treatment

Opioids for Pain Treatment. Opioids for Chronic Pain and Addiction Treatment. Outline for Today. Opioids for pain treatment Opioids for Chronic Pain and Addiction Treatment Joseph Merrill M.D., M.P.H. University of Washington February 24, 2012 Outline for Today Opioids for pain treatment Trends Problems High dose prescribing

More information

Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions

Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently Asked Questions What is Naltrexone? Naltrexone is a prescription drug that effectively blocks the effects of heroin, alcohol,

More information

Opioids and the Injured Worker Tools for Successful Outcomes

Opioids and the Injured Worker Tools for Successful Outcomes Opioids and the Injured Worker Tools for Successful Outcomes Tim Pokorney, RPh Director, Clinical Express Scripts Workers' Compensation Division Goals and Objectives Alarming statistics for narcotic utilization,

More information

OPIOIDS CONVERSION GUIDELINES 2007

OPIOIDS CONVERSION GUIDELINES 2007 Opioid analgesics vary in potency, side effect and pharmacokinetic profile. Therefore the Opioid Conversion Guidelines has been developed to assist when changing opioid drug therapy. When opioid rotating

More information

Alcohol Withdrawal. Introduction. Blood Alcohol Concentration. DSM-IV Criteria/Alcohol Abuse. Pharmacologic Effects of Alcohol

Alcohol Withdrawal. Introduction. Blood Alcohol Concentration. DSM-IV Criteria/Alcohol Abuse. Pharmacologic Effects of Alcohol Pharmacologic Effects of Alcohol Alcohol Withdrawal Kristi Theobald, Pharm.D., BCPS Therapeutics III Fall 2003 Inhibits glutamate receptor function (NMDA receptor) Inhibits excitatory neurotransmission

More information

Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients

Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients Jennifer Kuhns, Pharm.D. Pharmacy Practice Resident Children s Hospital of Michigan **The speaker has no actual or potential

More information

Palliative Medicine, Pain Management, and Hospice. Devon Neale, MD Assistant Professor Dept of Internal Medicine UNM School of Medicine

Palliative Medicine, Pain Management, and Hospice. Devon Neale, MD Assistant Professor Dept of Internal Medicine UNM School of Medicine Palliative Medicine, Pain Management, and Hospice Devon Neale, MD Assistant Professor Dept of Internal Medicine UNM School of Medicine Pall-i- What??? Objectives: Provide information about Palliative Medicine

More information

Tracy Walker, RN, BSN, CCRP Research Nurse OHSU Knight Cancer Institute. 503-346-1183 walkertr@ohsu.edu

Tracy Walker, RN, BSN, CCRP Research Nurse OHSU Knight Cancer Institute. 503-346-1183 walkertr@ohsu.edu Tracy Walker, RN, BSN, CCRP Research Nurse OHSU Knight Cancer Institute 503-346-1183 walkertr@ohsu.edu Exercise Questions to Keep in Mind Is there an adverse event? What is the severity? What is the relationship

More information

Opioid Dependence Treatment with Buprenorphine/Naloxone: An Overview for Pharmacists and Physicians

Opioid Dependence Treatment with Buprenorphine/Naloxone: An Overview for Pharmacists and Physicians Opioid Dependence Treatment with Buprenorphine/Naloxone: An Overview for Pharmacists and Physicians Phyllis A. Grauer, PharmD, CGP, CPE Clinical Pharmacist Legislation Passed Enabling Office Based Treatment

More information

STATISTICS. Opiate Substitution Therapy for Opiate Dependence. Alan Shein, M.D.

STATISTICS. Opiate Substitution Therapy for Opiate Dependence. Alan Shein, M.D. Opiate Substitution Therapy for Opiate Dependence Alan Shein, M.D. OH #1-1 STATISTICS Prevalence of Specific Drug Abuse and Vulnerability to Develop Addictions National Household Survey and Related Surveys

More information

PAIN AND/OR BENZODIAZEPINE MANAGEMENT 3002

PAIN AND/OR BENZODIAZEPINE MANAGEMENT 3002 521 4 th Street Havre Montana 59501 Phone: 406-395-4305 Fax: 406-395-5643 www.bullhook.com POLICY AND PROCEDURE PAIN AND/OR BENZODIAZEPINE MANAGEMENT 3002 Policy: Pain and/or Benzodiazepine Management

More information

Strong opioids (painkillers) in palliative care what you should know

Strong opioids (painkillers) in palliative care what you should know Strong opioids (painkillers) in palliative care what you should know Patient Information Author ID: JG Leaflet Number: PC 006 Version: 1 Name of Leaflet: Strong opioids (painkillers) in palliative care

More information

Conceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium

Conceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium Conceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of Medicine tvp@case.edu

More information

Opioid Conversion Ratios - Guide to Practice 2010

Opioid Conversion Ratios - Guide to Practice 2010 Opioid Conversion Ratios - Guide to Practice 2010 Released December 2010. 2010. The EMR PCC grants permission to reproduce parts of this publication for clinical and educational use only, provided that

More information

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Children s Hospital -2/11/13

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Children s Hospital -2/11/13 Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Children s Hospital -// What is Neonatal Abstinence Syndrome? Neonatal withdrawal after intrauterine exposure

More information

Best Practices for Patients With Pain. Commonly Used Over the Counter (OTC) Pain Relievers 5/15/2015

Best Practices for Patients With Pain. Commonly Used Over the Counter (OTC) Pain Relievers 5/15/2015 Faculty Best Practices for Patients With Pain Nancy Bishop, RPh Assistant State Pharmacy Director Alabama Department of Public Health Satellite Conference and Live Webcast Wednesday, May 20, 2015 2:00

More information